Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 457  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article


    Article Cited by others


O 6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: A review of current status

Suri Vaishali, Jha Prerana, Sharma Mehar Chand, Sarkar Chitra

Year : 2011| Volume: 59| Issue : 2 | Page no: 229-235

   This article has been cited by
1 Analysis of Outcomes of Multidisciplinary Management of Gliosarcoma: A Single-Center Study, 2000–2013
Abhinav Jain,Jason Correia,Patrick Schweder,Adele McMahon,Joseph Merola,Robert Aspoas
World Neurosurgery. 2017; 106: 30
[Pubmed]  [Google Scholar] [DOI]
2 An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Haley Gittleman,Daniel Lim,Michael W. Kattan,Arnab Chakravarti,Mark R. Gilbert,Andrew B. Lassman,Simon S. Lo,Mitchell Machtay,Andrew E. Sloan,Erik P Sulman,Devin Tian,Michael A. Vogelbaum,Tony J. C. Wang,Marta Penas-Prado,Emad Youssef,Deborah T. Blumenthal,Peixin Zhang,Minesh P. Mehta,Jill S. Barnholtz-Sloan
Neuro-Oncology. 2016; : now208
[Pubmed]  [Google Scholar] [DOI]
3 Protein Markers Predict Survival in Glioma Patients
Lindsay C. Stetson,Jean-Eudes Dazard,Jill S. Barnholtz-Sloan
Molecular & Cellular Proteomics. 2016; 15(7): 2356
[Pubmed]  [Google Scholar] [DOI]
4 Meningeal hemangiopericytomas: A clinicopathological study with emphasis on MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation status
Aanchal Kakkar,Anupam Kumar,Prerana Jha,Nishant Goyal,Supriya Mallick,Mehar Chand Sharma,Ashish Suri,Manmohan Singh,Shashank S Kale,Pramod Kumar Julka,Chitra Sarkar,Vaishali Suri
Neuropathology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
5 Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation
P. Jha,I. R. Pia Patric,S. Shukla,P. Pathak,J. Pal,V. Sharma,S. Thinagararanjan,V. Santosh,V. Suri,M. C. Sharma,A. Arivazhagan,A. Suri,D. Gupta,K. Somasundaram,C. Sarkar
Neuro-Oncology. 2014; 16(12): 1607
[Pubmed]  [Google Scholar] [DOI]
6 Impact of genetic targets on primary brain tumor therapy: Whatæs ready for prime time?
Zalatimo, O. and Zoccoli, C.M. and Patel, A. and Weston, C.L. and Glantz, M.
Advances in Experimental Medicine and Biology. 2013; 779: 267-289
[Pubmed]  [Google Scholar]
7 Gene markers in brain tumors: What the epileptologist should know
Quinn Ostrom,Mark L. Cohen,Annie Ondracek,Andrew Sloan,Jill Barnholtz-Sloan
Epilepsia. 2013; 54: 25
[Pubmed]  [Google Scholar] [DOI]
8 A study of clinico-pathological parameters and O6 - methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma
Singh, G. and Mallick, S. and Sharma, V. and Joshi, N. and Purkait, S. and Jha, P. and Sharma, M.C. and Suri, V. and Julka, P.K. and Mahapatra, A.K. and Singh, M. and Kale, S.S. and Sarkar, C.
Neuropathology. 2012; 32(5): 534-542
[Pubmed]  [Google Scholar]
9 Anaplastic Gliomas: Radiation, Chemotherapy, or Both?
Blondin, N.A. and Becker, K.P.
Hematology/Oncology Clinics of North America. 2012; 26(4): 811-823
[Pubmed]  [Google Scholar]
10 MGMT hypermethylation and MDR system in glioblastoma cancer stem cells
Caldera, V. and Mellai, M. and Annovazzi, L. and Monzeglio, O. and Piazzi, A. and Schiffer, D.
Cancer Genomics and Proteomics. 2012; 9(4): 171-178
[Pubmed]  [Google Scholar]
11 Drug resistance in glioblastoma: A mini review
Haar, C.P. and Hebbar, P. and Wallace IV, G.C. and Das, A. and Vandergrift III, W.A. and Smith, J.A. and Giglio, P. and Patel, S.J. and Ray, S.K. and Banik, N.L.
Neurochemical Research. 2012; 37(6): 1192-1200
[Pubmed]  [Google Scholar]
12 MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors
Mellai, M. and Monzeglio, O. and Piazzi, A. and Caldera, V. and Annovazzi, L. and Cassoni, P. and Valente, G. and Cordera, S. and Mocellini, C. and Schiffer, D.
Journal of Neuro-Oncology. 2012; 107(3): 617-631
[Pubmed]  [Google Scholar]
13 Glioblastoma biomarkers from bench to bedside: Advances and challenges
Farias-Eisner, G., Bank, A.M., Hwang, B.Y., Appelboom, G., Piazza, M.A., Bruce, S.S., Sander Connolly, E.
British Journal of Neurosurgery. 2012; 26(2): 189-194
[Pubmed]  [Google Scholar]
14 Anaplastic Gliomas
Nicholas A. Blondin,Kevin P. Becker
Hematology/Oncology Clinics of North America. 2012; 26(4): 811
[Pubmed]  [Google Scholar] [DOI]
15 A study of clinico-pathological parameters and O6- methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma
Geetika Singh,Supriyo Mallick,Vikas Sharma,Nikhil Joshi,Suvendu Purkait,Prerana Jha,Mehar Chand Sharma,Vaishali Suri,Pramod Kumar Julka,Ashok Kumar Mahapatra,Manmohan Singh,Shashank Sharad Kale,Chitra Sarkar
Neuropathology. 2012; 32(5): 534
[Pubmed]  [Google Scholar] [DOI]
16 MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors
Marta Mellai,Oriana Monzeglio,Angela Piazzi,Valentina Caldera,Laura Annovazzi,Paola Cassoni,Guido Valente,Susanna Cordera,Cristina Mocellini,Davide Schiffer
Journal of Neuro-Oncology. 2012; 107(3): 617
[Pubmed]  [Google Scholar] [DOI]
17 Drug Resistance in Glioblastoma: A Mini Review
Catherine P. Haar,Preetha Hebbar,Gerald C. Wallace,Arabinda Das,William A. Vandergrift,Joshua A. Smith,Pierre Giglio,Sunil J. Patel,Swapan K. Ray,Naren L. Banik
Neurochemical Research. 2012; 37(6): 1192
[Pubmed]  [Google Scholar] [DOI]
18 Silencing of MGMT with small interference RNA reversed resistance in human BCUN-resistant glioma cell lines
Xie, S.-M., Fang, M., Guo, H., Zhong, X.-Y.
Chinese Medical Journal. 2011; 124(17): 2605-2610
[Pubmed]  [Google Scholar]


Online since 20th March '04
Published by Wolters Kluwer - Medknow